Proteases
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
-
A1926 CA 0742 CitationTarget: CathepsinsSummary: Cathepsin B inhibitor
-
A8165 Q-VD(OMe)-OPh6 CitationTarget: CaspasesSummary: Pan-caspase inhibitor
-
A3126 5-R-RivaroxabanTarget: Factor XaSummary: Factor Xa (FXa) inhibitor
-
A3244 Bivalirudin TrifluoroacetateTarget: thrombinSummary: Reversible thrombin inhibitor
-
A3253 BMS-6265292 CitationTarget: HIV-1 gp120Summary: HIV-1 attachment inhibitor
-
B1037 AlvelestatTarget: NESummary: NE inhibitor
-
A8381 BIBR-1048Summary: Thrombin inhibitor
-
A8650 SaxagliptinTarget: DPP-4Summary: Selective DPP4 inhibitor
-
B3232 Z-IETD-FMK12 CitationTarget: CaspasesSummary: Caspase-8 inhibitor
-
A8189 PSI-62063 CitationTarget: HCV polymeraseSummary: Inhibitor of HCV RNA polymerase,potent and selective